Φορτώνει......
ICER, ISPOR AND QALYs: Tales of Imaginary Worlds
Previous commentaries in the Formulary Evaluation section of INNOVATIONS in Pharmacy have pointed to the lack of credibility in modeled claims for cost-effectiveness and associated recommendations for pricing by the Institute for Clinical and Economic Review (ICER). The principal objection to ICER r...
Αποθηκεύτηκε σε:
| Τόπος έκδοσης: | Innov Pharm |
|---|---|
| Κύριος συγγραφέας: | |
| Μορφή: | Artigo |
| Γλώσσα: | Inglês |
| Έκδοση: |
University of Minnesota Libraries Publishing
2019
|
| Θέματα: | |
| Διαθέσιμο Online: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8051886/ https://ncbi.nlm.nih.gov/pubmed/34007578 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.24926/iip.v10i4.2266 |
| Ετικέτες: |
Προσθήκη ετικέτας
Δεν υπάρχουν, Καταχωρήστε ετικέτα πρώτοι!
|